Lung Cancer Surgery Safe and Effective for Many Patients Over 80, Study Finds
For years, chronological age has often served as a primary barrier for older adults seeking curative treatment for lung cancer. However, fresh research indicates that for many octogenarians, surgery is not only a safe option but one that provides significant long-term benefits. A prospective cohort study published in The Lancet Regional Health: Americas reveals that patients aged 80 and older can recover well and achieve survival outcomes comparable to those of younger patients.
The IELCART Study: Challenging Age-Based Assumptions
Researchers from the Mount Sinai Health System conducted the Initiative for Early Lung Cancer Research on Treatment (IELCART) study to evaluate surgical outcomes in older populations. The study assessed 884 patients diagnosed with stage IA non-small cell lung cancer (NSCLC), with octogenarians representing 12.9% of the cohort.
Historically, patients over 80 have been frequently excluded from clinical trials and screening programs due to perceived age-related risks. The IELCART study sought to determine if these exclusions were justified or if a more nuanced approach to patient selection could improve outcomes.
Prioritizing Overall Health Over Chronological Age
The findings emphasize a critical shift in medical decision-making: the transition from using age as a hard cutoff to evaluating a patient’s comprehensive health status. According to the study, when patients are carefully selected based on their overall physiological health rather than their birth date, they can tolerate surgery well.
Raja M. Flores, MD, Chair of the Department of Thoracic Surgery at Mount Sinai Health System and lead study author, noted that although more patients over 80 are being diagnosed with early-stage lung cancer as life expectancy increases, they are often not considered for surgery. He stated that carefully selected patients can experience “excellent long-term outcomes.”
Impact on Survival and Quality of Life
The research demonstrates that surgical intervention for stage IA NSCLC in octogenarians is safe and leads to long-term quality-of-life benefits. The study found that these older adults can live just as long as younger patients following successful surgery.
Emanuela Taioli, MD, PhD, Director of the Institute for Translational Epidemiology at the Icahn School of Medicine and a study author, highlighted the necessity of equitable access to care. She argued that older adults are often left out of clinical decisions, despite the fact that effective treatments can improve both their survival and their quality of life.
Key Takeaways for Patients and Providers
- Health Status is Key: Surgical eligibility should be determined by a patient’s overall health and functional status, not solely by their age.
- Safe Outcomes: For carefully selected octogenarians with stage IA NSCLC, surgery is a safe and viable treatment option.
- Comparable Benefits: Older patients can achieve survival rates and quality-of-life improvements similar to those of younger patients.
- Addressing Gaps: There is a pressing need to ensure older adults have equal access to curative treatments and are not automatically excluded from surgical consideration.
Looking Ahead
As the global population ages, the prevalence of early-stage lung cancer in older adults will continue to rise. This research marks a pivotal step in redefining surgical eligibility, urging clinicians to move beyond age-based stereotypes to provide evidence-based, individualized care. By focusing on comprehensive health assessments, the medical community can ensure that life-saving surgical options are available to all patients who can benefit from them.
Related reading